Detalhe da pesquisa
1.
Structural basis of receptor recognition by SARS-CoV-2.
Nature
; 581(7807): 221-224, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-32225175
2.
Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection.
PLoS Pathog
; 17(9): e1009897, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34492082
3.
Cell entry mechanisms of SARS-CoV-2.
Proc Natl Acad Sci U S A
; 117(21): 11727-11734, 2020 05 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32376634
4.
Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry.
PLoS Pathog
; 16(3): e1008392, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32150576
5.
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
J Virol
; 94(7)2020 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-31996437
6.
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry.
J Virol
; 94(5)2020 02 14.
Artigo
Inglês
| MEDLINE | ID: mdl-31826992
7.
Lysosomal Proteases Are a Determinant of Coronavirus Tropism.
J Virol
; 92(24)2018 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30258004
8.
Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway.
J Immunol
; 194(6): 2757-68, 2015 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25681344
9.
Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1).
J Biol Chem
; 288(29): 20927-20941, 2013 Jul 19.
Artigo
Inglês
| MEDLINE | ID: mdl-23729669
10.
A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies.
JCI Insight
; 9(5)2024 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-38456504
11.
Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein.
Elife
; 122023 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37991488
12.
Molecular switches regulating the potency and immune evasiveness of SARS-CoV-2 spike protein.
Res Sq
; 2021 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34611654
13.
The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates.
Elife
; 102021 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34338634
14.
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2.
bioRxiv
; 2020 Nov 17.
Artigo
Inglês
| MEDLINE | ID: mdl-33236012
15.
Inducible GBP5 Mediates the Antiviral Response via Interferon-Related Pathways during Influenza A Virus Infection.
J Innate Immun
; 9(4): 419-435, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28376501
16.
Inducible Rubicon facilitates viral replication by antagonizing interferon production.
Cell Mol Immunol
; 14(7): 607-620, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28392573
17.
Hepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action.
Sci Rep
; 7(1): 1729, 2017 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28496097
18.
Hepatitis B Virus Stimulated Fibronectin Facilitates Viral Maintenance and Replication through Two Distinct Mechanisms.
PLoS One
; 11(3): e0152721, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27023403
19.
Mir-302c mediates influenza A virus-induced IFNß expression by targeting NF-κB inducing kinase.
FEBS Lett
; 589(24 Pt B): 4112-8, 2015 Dec 21.
Artigo
Inglês
| MEDLINE | ID: mdl-26602079
20.
MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1.
Protein Cell
; 4(2): 130-41, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23150165